Form 4: Neuronetics CEO Awarded Performance-Based Stock Units

Neuronetics CEO Keith J. Sullivan was granted 450,000 performance-based restricted stock units (PRSUs) that vest upon achieving cash flow breakeven targets in 2025.

Summary

• Neuronetics CEO Keith J. Sullivan received a grant of 450,000 performance restricted stock units (PRSUs) on December 10, 2024.
• These PRSUs will vest on December 31, 2025, contingent upon the company achieving specific cash flow breakeven targets.
• 25% of the award vests if Neuronetics achieves cash flow breakeven for the quarter ending June 30, 2025.
• An additional 50% vests if the company achieves cash flow breakeven for the quarter ending September 30, 2025.
• The final 25% vests if cash flow breakeven is achieved for the quarter ending December 31, 2025.
• Each PRSU represents the right to receive one share of Neuronetics common stock upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a positive incentive structure for the CEO, aligning his interests with the company's financial goals. The sentiment is neutral to positive as it is a standard practice.

Positives

• The performance-based vesting of the stock units aligns management's interests with the company's financial goals.
• The vesting schedule provides clear targets for achieving cash flow breakeven in 2025.

Risks

• The vesting of the stock units is contingent on achieving cash flow breakeven, which may not be guaranteed.
• Failure to meet the cash flow breakeven targets will result in the CEO not receiving the full award.

Future Outlook

The vesting of the PRSUs is tied to the company achieving cash flow breakeven in specific quarters of 2025, indicating a focus on financial performance.

Industry Context

Performance-based equity awards are a common practice in the industry to incentivize management to achieve specific financial and operational goals.

Comparison to Industry Standards

• Performance-based equity awards are a standard practice in the biotech and medical device industries, often tied to milestones such as revenue growth, profitability, or regulatory approvals.
• Many companies in the sector use similar vesting schedules tied to financial performance metrics.
• For example, companies like InMode and Shockwave Medical also use performance-based equity awards to align management incentives with shareholder value creation.

Stakeholder Impact

• Shareholders may view the performance-based award positively, as it aligns management's interests with achieving financial targets.
• Employees may see this as a positive sign of the company's commitment to growth and financial stability.

Key Dates

Keywords

performance restricted stock units, PRSU, cash flow breakeven, executive compensation, stock award, Neuronetics, Keith J. Sullivan